Mei et al., 2013 - Mechanisms of prickle 1a function in zebrafish epilepsy and retinal neurogenesis. Disease models & mechanisms   6(3):679-688 Full text @ Dis. Model. Mech.

Fig. 2 pk1a knockdown sensitizes zebrafish to PTZ treatment. (A-C) Morphology of wild-type and pk1a-MO-injected embryos at 2 dpf: wild-type uninjected embryo (A); pk1a-MO-injected embryos ranging from ‘normal-like’ (B) to curved body axis (C). (D) Graph of total half-hour activity before and after PTZ treatment for larvae injected with control-MO and pk1a-MO. Wilcoxon Rank Sum test found no significant increase (ns) in activity of control-MO and pk1a-MO injected larvae prior to PTZ treatment. There was a significant increase in activity in control after PTZ compared with control before PTZ (P<0.05) and for pk1a morphants after PTZ compared with before PTZ (P<0.05). *P<0.05 is the significant difference between control and pk1a morphant after PTZ treatment. For control-MO, n=48 and for pk1a-MO, n=48. Data presented as mean ± s.e.m.

Fig. 3 pk1a is expressed in the brain and retina and is not required for overall retinal lamination. (A,B) Whole-mount in situ hybridization of 3 dpf embryos. Images are from the dorsal view. An antisense RNA riboprobe is used to determine the expression pattern of pk1a, and a riboprobe from the sense strand is used as a control. (C,D) Sections of the eye after whole-mount in situ hybridization at 3 dpf: sense control (C) and pk1a antisense (D). Arrows show different layers in the retina. (E–G′′) H&E staining of eye sections at 76–78 hpf. (E–G) Whole retina sections of uninjected (E), control-MO-injected (F) and pk1a-MO-injected larvae (G); magnification 40×. (E′–G′′) Enlarged areas of the white boxes in E–G; the arrowhead in G′′ indicates nuclei disorganization; magnification 63×. PR, photo-receptors; INL, inner nuclear layer; IPL, inner plexiform layer; RGCs, retina ganglion cells; OPL, outer plexiform layer; ONL, outer nuclear layer. Scale bars: 5 μm.

Fig. 4 pk1a knockdown induces inner plexiform layer defects. (A–H′) Sections at 76–78 hpf in the HuC:gfp transgenic line. Green channel, GFP; blue channel, To-Pro3 nuclear counter-staining. (A–H) Whole eye visualized at 63×. Representative sections from uninjected embryos (A) and from embryos injected with control-MO (B); pk1a-MO, showing severe IPL defects (C); pk1a-MO, showing mild IPL defects (D); a second pk1a-MO (E); 40 pg pk1a RNA (F); 80 pg pk1a RNA (G); pk1a-MO plus 40 pg pk1a RNA (H). (A′–H′) Digital 3× zoom of the white boxed areas in A–H, showing the green channel only. In the uninjected (A′) and control-MO-injected embryos (B′), there are two clearly stratified tracks. pk1a morphants exhibit either loss of the organization (C′) or discontinuous tracks (arrowheads in D′). A second pk1a-MO also induced similar IPL defects (E′). Although a low dose of pk1a RNA injection does not show a defect (F′), a higher dose does (G′). The defects can be partially suppressed by a low dose pk1a RNA co-expression (H′). Scale bar: 10 μm.

Fig. 6 pk1a epilepsy mutants display distinct biochemical properties. (A) Western blot of myc-tagged wild-type (wtPk1) and mutant forms of Pk1a. Protein lysates were made at 80% epiboly stage. β-actin was used as a loading control. (B) Pull-down assays showing the extent to which wild-type (wt) and mutant forms are ubiquitylated. HA-Ub and pk1a RNAs were co-injected into one-cell stage embryos and at 80% epiboly total cell lysates were pulled down by anti-myc antibody beads and blotted for anti-myc or anti-HA. Embryos injected with HA-Ub without pk1a RNA were subjected to anti-myc pull-down as a negative control.

Fig. S3

pk1a knockdown does not significantly impair visual functions. (A-C) Bright-field images selected from a movie during vision assay at 5 dpf. (A) larva under bright light illumination. (B) A short period of darkness. (C) Characteristic change of swimming direction after light change. Numbers in the images indicate the time points in “second : millisecond”. (D) Vision assay plotted by average number of times an embryo was scored as “positive” out of five trials. Wild-type uninjected embryos respond at an average of 3.6 times, while crx-MO injected embryos respond only 2.2 times. pk1a-MO morphants respond 3.0 times, which is not significantly different from wild-type embryos. *P<0.01; ns, not significant, ANOVA, uninjected n=49, crx-MO n=20, pk1a-MO n=46.

Knockdown Reagent:
Observed In:
Stage: Day 5
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Dis. Model. Mech.